Passage Bio, Inc. Common Stock

PASG XNAS • BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

16M

Short interest (Jul 15)

3.9%

Net Short (Jul 27 ): -0.1%

Borrow Fee

0.44%

↑ 30.0%

Available Shares

200K

↑ 6.7%

Price Chart

Company Overview

Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to target critical underlying pathologies in these conditions. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target the critical underlying pathology of neurodegenerative diseases. The pipeline having PBFT02.

Company Info

Exchange: NASDAQ

Industry: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

CIK: 0001787297

Asset Type: CS

Market Data

Market Cap: $15,871,281

Employees: 24

Status: Active

Short Interest

Current Borrow Fee 0.44%

Range: 0.41% - 0.44%

Available Shares 200K

Range: 200K - 250K

Recent Changes

Fee Change: ↑ 3.7%

Available Change: ↓ 10.0%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime